Blair William & CO Novo Nordisk A S Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Blair William & CO holds 79,693 shares of NVO stock, worth $6.96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

79,693

Previous 80,415 0.9%

Holding current value

$6.96 Million

Previous $11.5 Million 17.33%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $85,968 - $104,993	-722 Reduced 0.9%	79,693 $9.49 Million
Q2 2024 Aug 12, 2024	BUY	$122.71 - $146.91 $1.15 Million - $1.38 Million	9,379 Added 13.2%	80,415 $11.5 Million
Q1 2024 May 09, 2024	BUY	$102.11 - $135.92 $829,745 - $1.1 Million	8,126 Added 12.92%	71,036 $9.12 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $1.05 Million - $1.26 Million	11,948 Added 23.44%	62,910 $6.51 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $2.67 Million - $5.85 Million	29,318 Added 135.46%	50,962 $4.63 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $369,048 - $408,489	2,366 Added 12.27%	21,644 $3.5 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $532,139 - $639,901	4,021 Added 26.36%	19,278 $3.07 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $547,206 - $722,120	-5,336 Reduced 25.91%	15,257 $2.06 Million
Q3 2022 Nov 09, 2022	BUY	$95.28 - $116.93 $41,923 - $51,449	440 Added 2.18%	20,593 $2.05 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $70,925 - $83,683	687 Added 3.53%	20,153 $2.25 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $204,261 - $246,912	2,194 Added 12.7%	19,466 $2.14 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $193,965 - $236,852	2,023 Added 13.27%	17,272 $1.93 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $106,875 - $134,980	1,266 Added 9.05%	15,249 $1.46 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $162,519 - $203,593	-2,402 Reduced 14.66%	13,983 $1.17 Million
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $221,029 - $249,902	-3,296 Reduced 16.75%	16,385 $1.11 Million
Q4 2020 Feb 09, 2021	SELL	$63.89 - $73.8 $240,737 - $278,078	-3,768 Reduced 16.07%	19,681 $1.38 Million
Q3 2020 Nov 06, 2020	BUY	$63.69 - $70.22 $41,653 - $45,923	654 Added 2.87%	23,449 $1.63 Million
Q2 2020 Aug 12, 2020	SELL	$58.54 - $67.94 $31,260 - $36,279	-534 Reduced 2.29%	22,795 $1.49 Million
Q1 2020 May 11, 2020	BUY	$49.46 - $64.78 $42,931 - $56,229	868 Added 3.86%	23,329 $1.4 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $385,916 - $450,932	7,740 Added 52.58%	22,461 $1.3 Million
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $112,574 - $126,522	-2,368 Reduced 13.86%	14,721 $761,000
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $65,973 - $73,982	-1,410 Reduced 7.62%	17,089 $872,000
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $112,793 - $128,048	2,433 Added 15.14%	18,499 $968,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $6 Million - $6.83 Million	-144,535 Reduced 90.0%	16,066 $740,000
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $647,766 - $709,827	13,853 Added 9.44%	160,601 $7.57 Million
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $2.22 Million - $2.53 Million	-50,159 Reduced 25.47%	146,748 $6.77 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $93,876 - $112,559	-1,936 Reduced 0.97%	196,907 $9.7 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $782,724 - $884,825	16,468 Added 9.03%	198,843 $10.7 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $7.5 Million - $8.98 Million	182,375	182,375 $8.78 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account